This decrease in cytotoxic protein expression led to delayed tumor clearance, which caused PRDM1 KO CAR T-cells to be exposed to target cancer cells for twice as long as control CAR T-cells (Fig. 6F and G). The gene discussed is PRDM1; the disease is cancer.